Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology.
Donato P, Roberts MJ, Morton A, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Yaxley J. Donato P, et al. Among authors: morton a. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):20-30. doi: 10.1007/s00259-018-4160-7. Epub 2018 Sep 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 30229528
68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
Donato P, Morton A, Yaxley J, Ranasinghe S, Teloken PE, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Roberts MJ. Donato P, et al. Among authors: morton a. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1843-1851. doi: 10.1007/s00259-019-04620-0. Epub 2020 Jan 7. Eur J Nucl Med Mol Imaging. 2020. PMID: 31912257
68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.
Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, Coughlin G, Esler R, Dunglison N, Gardiner RA, Doi SA, Emmett L, Yaxley J. Roberts MJ, et al. Among authors: morton a. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):477-482. doi: 10.1007/s00259-020-04944-2. Epub 2020 Jul 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 32696091
Correction to: 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer.
Roberts MJ, Morton A, Donato P, Kyle S, Pattison DA, Thomas P, Coughlin G, Esler R, Dunglison N, Gardiner RA, Doi SA, Emmett L, Yaxley J. Roberts MJ, et al. Among authors: morton a. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):655-656. doi: 10.1007/s00259-020-04983-9. Eur J Nucl Med Mol Imaging. 2021. PMID: 32918575 No abstract available.
Images - Acute urinary retention due to urethral steinstrasse.
Morton A, Gordon L, Fowler R, Esler R, Dunglison N, Roberts MJ. Morton A, et al. Can Urol Assoc J. 2021 May;15(5):E299-E300. doi: 10.5489/cuaj.6725. Can Urol Assoc J. 2021. PMID: 33119499 Free PMC article. No abstract available.
External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study.
Meijer D, van Leeuwen PJ, Roberts MJ, Siriwardana AR, Morton A, Yaxley JW, Samaratunga H, Emmett L, van de Ven PM, van der Poel HG, Donswijk ML, Boellaard TN, Schoots IG, Oprea-Lager DE, Coughlin GD, Vis AN. Meijer D, et al. Among authors: morton a. Eur Urol. 2021 Aug;80(2):234-242. doi: 10.1016/j.eururo.2021.05.006. Epub 2021 May 21. Eur Urol. 2021. PMID: 34024652 Free article.
1,463 results